|
Hassanieh, Loubna; Rodriguez, Dorothy; Xu, Jinsong et al. (2003) Generation of a monoclonal antibody to a cryptic site common to both integrin beta1 as well as gelatinase MMP9. Hybrid Hybridomics 22:285-92
|
|
Hangai, Masanori; Kitaya, Norihiko; Xu, Jingsong et al. (2002) Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am J Pathol 161:1429-37
|
|
Brooks, Peter C; Roth, Jennifer M; Lymberis, Stella C et al. (2002) Ionizing radiation modulates the exposure of the HUIV26 cryptic epitope within collagen type IV during angiogenesis. Int J Radiat Oncol Biol Phys 54:1194-201
|
|
Stefansson, S; Petitclerc, E; Wong, M K et al. (2001) Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1. J Biol Chem 276:8135-41
|
|
McMahon, G A; Petitclerc, E; Stefansson, S et al. (2001) Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 276:33964-8
|
|
Xu, J; Rodriguez, D; Petitclerc, E et al. (2001) Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 154:1069-79
|
|
Petitclerc, E; von Schalscha, T; Brooks, P C (2000) The chimeric human/mouse model of angiogenesis. Methods Mol Biol 137:213-21
|
|
Petitclerc, E; Boutaud, A; Prestayko, A et al. (2000) New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 275:8051-61
|
|
Xu, J; Rodriguez, D; Kim, J J et al. (2000) Generation of monoclonal antibodies to cryptic collagen sites by using subtractive immunization. Hybridoma 19:375-85
|
|
Petitclerc, E; Stromblad, S; von Schalscha, T L et al. (1999) Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res 59:2724-30
|
